About this trial
This prospective, observational study investigates the relationship between early oxygen exposure and oxidative stress in adult intensive care unit patients with sepsis or septic shock. Fraction of inspired oxygen (FiO₂) administered during the first 24 hours of ICU admission will be recorded and analyzed in relation to changes in the uric acid/albumin ratio (UAR), a biomarker reflecting oxidative burden and inflammation. Serum uric acid and albumin levels will be measured at baseline and at 24 hours, and the percentage change in UAR will be calculated. Secondary analyses will examine associations between UAR changes, oxygenation indices, and 28-day mortality. The study aims to determine whether higher FiO₂ exposure is associated with increased oxidative stress and to evaluate the potential role of UAR as a clinically accessible marker of oxygen-related oxidative injury in septic ICU patients.
Eligibility criteria
Qualifiers
Adult patients aged 18-65 years
Patients undergoing elective septorhinoplasty
Surgery performed under general anesthesia
Complete recording of early postoperative VAS pain scores, Aldrete scores, NUDES scores, and vital signs in the Post-Anesthesia Care Unit (PACU)
Disqualifiers
Patients undergoing emergency surgery
Septorhinoplasty combined with additional major surgical procedures (e.g., advanced ENT or maxillofacial surgery)
Presence of known hematological disease, active infection, immunosuppressive therapy, or advanced liver or renal failure
Chronic opioid use or regular analgesic medication use in the preoperative period
Trial design
Treatments tested in this trial
- Observational Study